O-mel-sora: A national multicenter phase II trial of sorafenib in metastatic uveal melanoma.
Frédéric Mouriaux
No relevant relationships to disclose
Vincent Servois
No relevant relationships to disclose
Sophie Piperno-Neumann
No relevant relationships to disclose
Thierry Lesimple
No relevant relationships to disclose
Antoine Thyss
No relevant relationships to disclose
Thomas Jouary
No relevant relationships to disclose
Eve-Marie Neidhardt
No relevant relationships to disclose
Nicolas Penel
No relevant relationships to disclose
Corinne Delcambre
No relevant relationships to disclose
Jean-Jacques Parienti
No relevant relationships to disclose
Caroline Serre-Henry
No relevant relationships to disclose
Florence Joly
No relevant relationships to disclose